The store will not work correctly when cookies are disabled.
1-(4-cyclobutyl-3H-pyrrol-2-yl)-3-(isoquinolin-8-yl)urea
ID: ALA1241758
PubChem CID: 52947886
Max Phase: Preclinical
Molecular Formula: C18H18N4O
Molecular Weight: 306.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cc(C2CCC2)c[nH]1)Nc1cccc2ccncc12
Standard InChI: InChI=1S/C18H18N4O/c23-18(22-17-9-14(10-20-17)12-3-1-4-12)21-16-6-2-5-13-7-8-19-11-15(13)16/h2,5-12,20H,1,3-4H2,(H2,21,22,23)
Standard InChI Key: JAPIBZGEANTMOW-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
18.8319 -8.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8307 -8.9232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2591 -8.0922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5438 -7.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2620 -8.9227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5447 -9.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5432 -10.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2581 -10.5734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9761 -10.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9742 -9.3337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1163 -9.3357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4018 -8.9233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6874 -9.3359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4017 -8.0983 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9726 -8.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9714 -8.1009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1872 -7.8444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7009 -8.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1846 -9.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8792 -8.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2969 -7.9243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7124 -8.5066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2946 -9.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 11 1 0
11 12 1 0
5 6 1 0
12 13 1 0
5 3 1 0
12 14 2 0
6 7 2 0
13 15 1 0
15 16 1 0
1 2 2 0
7 8 1 0
3 4 2 0
8 9 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 15 2 0
20 21 1 0
4 1 1 0
9 10 1 0
10 5 2 0
2 6 1 0
21 22 1 0
22 23 1 0
23 20 1 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.37 | Molecular Weight (Monoisotopic): 306.1481 | AlogP: 4.47 | #Rotatable Bonds: 3 |
Polar Surface Area: 69.81 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.15 | CX Basic pKa: 4.95 | CX LogP: 3.29 | CX LogD: 3.28 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.67 | Np Likeness Score: -0.88 |
References
1. Sridhar J, Akula N, Pattabiraman N.. (2006) Selectivity and potency of cyclin-dependent kinase inhibitors., 8 (1): [PMID:16584130] [10.1208/aapsj080125] |